CPR Invest - Biodiversity - I EUR - Acc ISIN : LU3110816082

CPR Invest - Biodiversity - I EUR - Acc
I EUR(C) - LU3110816082
Asset class: Equities

Risk IndicatorThe level of risk of the fund mainly reflects the risk of the market in which the fund is invested and, as the case may be, the leveraging strategy or inverse performance of the index. The capital initially invested does not benefit from any guarantee. The current level of risk does not indicate the future level of risk and may change over time. The lowest risk level is not equal to a risk-free investment.
1234567
Lower Risk
Higher Risk
The risk indicator assumes you keep the product according to the holding period.

NAV
As of 27/08/2026
€117.05

SFDR ClassificationSustainable Finance Disclosure Regulation
Art. 8

Fund AUM
As of 27/08/2026
€224.87M

NAVs

NAV from 11/19/2025 to 08/27/2026
Select period
Created with Highcharts 11.4.8CPR Invest - Biodiversity - I EUR - Acc15 Dec12 Jan9 Feb9 Mar6 Apr4 May1 Jun29 Jun27 Jul24 Aug95100105110115120125

Performance

Change in NAV in base 100
The automatic display of performance will only be possible once the fund has a history of more than one year.
The automatic display of performance will only be possible once the fund has a history of more than one year.

Portfolio Analysis

Repartition

Characteristics

General data

Inception date
20/10/2025
First Nav Date
19/11/2025
Currency
EUR
Show more
Valuation
Daily
Minimum initial investment
100000 euros
Minimum additional investment
1 10/1000° share(s)/equity

Costs Composition

One-off costs upon entry or exit (Investment EUR 10,000)If you exit after 1 year
Entry costsThis includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge.Up to €500.00
Exit costsWe do not charge an exit fee for this product, but the person selling you the product may do so.€0.00
Ongoing costs taken each year (Investment EUR 10,000)
Management fees and other administrative or operating costs0.81% of the value of your investment per year. This percentage is based on actual costs over the last year.€76.95
Transaction costs0.20% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the underlying investments for the product. The actual amount will vary depending on how much we buy and sell.€19.00
Incidental costs taken under specific conditions (Investment EUR 10,000)
Performance fees

15.00% annual outperformance of the reference asset 100% MSCI WORLD NR Close. The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years.

The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset.

€0.00

Codification

ISIN code
LU3110816082
Bloomberg code
CPIBIEA LX
Reuters code

Documents

LanguageDocumentsTypeClosing Date
NL
PDF
03/08/2026
PDF
31/01/2026
EN
PDF
31/07/2025
PDF
07/05/2026
EN
PDF
31/12/2024
Prices expressed in a currency other than the base currency of the portfolio are available for information purposes only.
Nothing contained in this site constitutes a solicitation or offer by any member of the Amundi to provide any investment advice or service or to purchase or sell any financial instruments. The information it contains aims to inform the subscriber by providing information on the UCITS supplemental to that appearing in the Information Memorandum. The material provided on this site is presented as of the date shown and "as is". Amundi does not expressly or impliedly warrant the accuracy of the information provided on this site and expressly disclaims any warranties of fitness of this site for any particular purpose. This material reflects the opinion of the management company at the date of printing. The material is based upon information that we consider reliable, but we do not represent it is accurate, complete, valid or timely and it should not be relied on as such for any particular purpose. Any subscription should be based solely on the Information Memorandum provided to subscribers prior to the subscription and/or available upon request.
The collective inestment scheme (UCITS) has been recognised for public marketing in the Netherlands  by the Authority for The Financial Markets (AFM)